Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
IMUX
#3021
Immunic, Inc. Common Stock
1.0
2
+10.87%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+10.87%
Monatliche Änderung
+61.90%
6 month change
+17.24%
Jahresänderung
-8.93%
Vorheriger Schlusskurs
0.9
2
Open
1.0
2
Bid
Ask
Low
1.0
2
High
1.0
2
Volumen
18
Märkte
Aktien
Gesundheitswesen
IMUX
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
21.17 M
27.91 M
44.4 M
89.93 M
90.15 M
130.46 M
—
Valuation ratios
Enterprise value
196.21 M
180.21 M
-44.58 M
83.72 M
54.45 M
54.15 M
228.69 M
Price to earnings ratio
—
-2.44
-0.37
-0.69
-1
-0.86
-3.81
Price to sales ratio
—
52.25
9.36
122.88
3 339.16
—
—
Price to cash flow ratio
—
2.72
0.68
0.91
1.18
0.97
4.34
Price to book ratio
—
1.78
0.39
2.22
5.44
12.45
15.7
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.26
0.67
0.94
1.72
2.46
4.04
3.11
Return on equity %
0.28
0.73
1.06
3.24
5.45
14.56
10.94
Return on invested capital %
634.13
965.96
2 166.6
14.62 K
13.8 K
13.83 K
—
Gross margin %
100
100
100
100
100
200
800
Operating margin %
1 937.14
2 116
2 511.84
18.97 K
326.84 K
-20.77 K
-160.85 K
EBITDA margin %
—
—
—
—
—
20.94 K
161.39 K
Net margin %
1 741.18
2 145.54
2 531.15
17.9 K
335.02 K
-19.55 K
-155.78 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
15.93
9.21
9.62
2.12
1.77
0.75
4.98
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.02
0.03
0.04
0.01
0
-0.02
-0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
3.52
2.05
1.6
0.85
0.55
0.63
EBIT per share
—
—
—
—
—
-0.67
-0.76
EBITDA per share
—
—
—
—
—
-0.67
-0.76
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
3.67
3.66
1.05
0.36
0.1
0.84
Net current asset value per share
—
4.44
3.96
1.19
0.39
0.15
0.99
Tangible book value per share
—
3.98
3.57
0.65
0.18
0.04
0.41
Working capital per share
—
3.96
3.54
0.63
0.17
-0.05
0.18
Book value per share
—
5.37
3.57
0.65
0.18
0.04
0.41
Nachrichten
Immunic schließt Finanzierung über 200 Mio. US-Dollar ab; weitere 200 Mio. US-Dollar möglich
Immunic closes $200 million financing, may receive additional $200m
Why Is Immunic Stock Soaring Friday? - Immunic (NASDAQ:IMUX)
Privatplatzierung über 400 Mio. US-Dollar beflügelt Immunic-Aktie
Immunic stock soars after $400 million private placement deal
Immunic secures up to $400 million in private placement financing
Immunic Stock Jumps After Pricing $400 Million Private Placement - Immunic (NASDAQ:IMUX)
2 ‘Strong Buy’ Stocks to Buy Today, 2/9/2026, According to Top Analysts - TipRanks.com
Immunic präsentiert auf ACTRIMS-Forum neue Daten zu MS-Wirkstoff
Immunic to present additional data on MS drug at ACTRIMS forum
Verstoß gegen Mindestkurs: Immunic wechselt an den Nasdaq Capital Market
Immunic to transfer listing to Nasdaq Capital Market after bid price non-compliance